News & Insights

OrbiMed Raises Over $4.3 Billion Across Private Investment Funds
OrbiMed Logo

Orbimed News

OrbiMed Raises Over $4.3 Billion Across Private Investment Funds

Read More
link
Filter by Type
All
Orbimed News
Portfolio News

Portfolio News

Tune into Business in Biotech podcast with Tal Zaks! Click to watch:

Read More link
Edgewise Logo

Portfolio News

Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2...

Read More link
Cyrus Biotechnology Logo

Portfolio News

Cyrus Biotechnology Announces Potent in vivo Redosability of an Engineered IdeS...

Read More link
Scorpion Therapeutics Logo

Portfolio News

Scorpion Therapeutics Provides Clinical Program Updates for Its Mutant-Selective...

Read More link
InspireMD Logo

Portfolio News

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of...

Read More link
Crinetics Pharmaceuticals Logo

Portfolio News

Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for...

Read More link
Disc Medicine Logo

Portfolio News

Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients...

Read More link
NextCure Logo

Portfolio News

NextCure Announces Acceptance of IND Application for LNCB74

Read More link
Angitia Logo

Portfolio News

Angitia raises $120M for trio of clinical-stage biologics

Read More link
Janux Logo

Portfolio News

Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by...

Read More link
Neuropace Logo

Portfolio News

NeuroPace Completes Enrollment in Feasibility Study of RNS System for...

Read More link
Congruence Therapeutics Logo

Portfolio News

Congruence and Ono Announce Multi-Target Research Collaboration to Generate Small...

Read More link
img img img img img img img img img